![]() Stoke Therapeutics Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases. | ||
Founding Date | Founding Date 2013 | Founding Date 2014 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Kuopio, FI HQ | Locations Bedford, US HQ Cambridge, US |
Employees | Employees 338 | Employees 1106% decrease |

Stoke Therapeutics is a developer of antisense oligonucleotide medicines that target ribonucleic acid (RNA) splicing to enhance gene expression for the treatment of genetic diseases.
View company